Lexaria Bioscience Corp (LEXX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 08/31
| 08-2018 | 05-2018 | 02-2018 | 11-2017 | 08-2017 | |
| Sales | 96 | 140 | 172 | 25 | 0 |
| Cost of Goods | 3 | 2 | 14 | 6 | N/A |
| Gross Profit | 93 | 138 | 158 | 19 | N/A |
| Operating Expenses | 1,187 | 3,402 | 1,372 | 466 | 0 |
| Operating Income | -1,091 | -3,262 | -1,200 | -441 | N/A |
| Other Income | -136 | -163 | -178 | -138 | 0 |
| Pre-tax Income | -1,227 | -3,425 | -1,378 | -579 | 0 |
| Net Income Continuous | -1,227 | -3,425 | -1,378 | -579 | N/A |
| Net Income | $-1,227 | $-3,425 | $-1,378 | $-579 | $N/A |
| EPS Basic Total Ops | -0.30 | -1.50 | -0.60 | -0.30 | N/A |
| EPS Basic Continuous Ops | -0.51 | -1.45 | -0.59 | -0.25 | N/A |
| EPS Diluted Total Ops | -0.30 | -1.50 | -0.60 | -0.30 | N/A |
| EPS Diluted Continuous Ops | -0.51 | -1.45 | -0.59 | -0.25 | N/A |
| EBITDA(a) | $-1,090 | $-3,261 | $-1,200 | $-441 | $N/A |